EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

MerTK is a mediator of alpha-synuclein fibril uptake by human microglia

Marie-France Dorion iD, Moein Yaqubi, Konstantin Senkevich, Nicholas W Kieran, Adam MacDonald, Carol X Q Chen, Wen Luo, Amber Wallis, Irina Shlaifer, Jeffery A Hall, Roy W R Dudley, Ian A Glass und 8 weitere

Brain · 01.02.2024 · 147 (2) · 427-443

DOI: 10.1093/brain/awad298 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Brain, online erschienen am 06.09.2023. Verfasst von Marie-France Dorion und 19 weiteren Autor:innen. Beteiligte Einrichtung: Early Drug Discovery Unit, Montreal Neurological Institute-Hospital, McGill University, Montreal H3A 2B4, Canada. Hauptthemen laut MEDLINE: Lewy Body Disease, Parkinson Disease, Synucleinopathies. Die Arbeit wurde bisher 47-mal zitiert (Crossref) und nennt 79 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NICHD NIH HHS, Canadian Institutes of Health Research, Canada First Research Excellence Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mer tyrosine kinase (MerTK) is a receptor tyrosine kinase that mediates non-inflammatory, homeostatic phagocytosis of diverse types of cellular debris. Highly expressed on the surface of microglial cells, MerTK is of importance in brain development, homeostasis, plasticity and disease. Yet, involvement of this receptor in the clearance of protein aggregates that accumulate with ageing and in neurodegenerative diseases has yet to be defined. The current study explored the function of MerTK in the microglial uptake of alpha-synuclein fibrils which play a causative role in the pathobiology of synucleinopathies. Using human primary and induced pluripotent stem cell-derived microglia, the MerTK-dependence of alpha-synuclein fibril internalization was investigated in vitro. Relevance of this pathway in synucleinopathies was assessed through burden analysis of MERTK variants and analysis of MerTK expression in patient-derived cells and tissues. Pharmacological inhibition of MerTK and siRNA-mediated MERTK knockdown both caused a decreased rate of alpha-synuclein fibril internalization by human microglia. Consistent with the non-inflammatory nature of MerTK-mediated phagocytosis, alpha-synuclein fibril internalization was not observed to induce secretion of pro-inflammatory cytokines such as IL-6 or TNF, and downmodulated IL-1β secretion from microglia. Burden analysis in two independent patient cohorts revealed a significant association between rare functionally deleterious MERTK variants and Parkinson’s disease in one of the cohorts (P = 0.002). Despite a small upregulation in MERTK mRNA expression in nigral microglia from Parkinson’s disease/Lewy body dementia patients compared to those from non-neurological control donors in a single-nuclei RNA-sequencing dataset (P = 5.08 × 10−21), no significant upregulation in MerTK protein expression was observed in human cortex and substantia nigra lysates from Lewy body dementia patients compared to controls. Taken together, our findings define a novel role for MerTK in mediating the uptake of alpha-synuclein fibrils by human microglia, with possible involvement in limiting alpha-synuclein spread in synucleinopathies such as Parkinson’s disease. Upregulation of this pathway in synucleinopathies could have therapeutic values in enhancing alpha-synuclein fibril clearance in the brain.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lewy Body DiseaseParkinson DiseaseSynucleinopathiesHumansalpha-Synucleinc-Mer Tyrosine KinaseMicrogliaProtein-Tyrosine Kinases

Stichwörter der Autor:innen

MerTKParkinson’s diseasealpha-synucleinmicrogliaphagocytosis

Substanzen

alpha-Synucleinc-Mer Tyrosine KinaseProtein-Tyrosine KinasesMERTK protein, humanSNCA protein, human

Autor:innen und Institutionen

  • Early Drug Discovery Unit, Montreal Neurological Institute-Hospital, McGill University, Montreal H3A 2B4, Canada.
  • Neuroimmunology Unit, Montreal Neurological Institute-Hospital, McGill University, Montreal H3A 2B4, Canada.
  • Department of Neurology and Neurosurgery, Montreal Neurological Institute-Hospital, McGill University, Montreal H3A 2B4, Canada.
  • McGill Parkinson Program and Neurodegenerative Diseases Group, Montreal Neurological Institute-Hospital, McGill University, Montreal H3A 2B4, Canada.
  • Department of Human Genetics, McGill University, Montreal H3A 0C7, Canada.
  • UK Dementia Research Institute, University College London, London WC1E 6BT, UK.

ORCID-Profile: Marie-France Dorion, Edward A Fon, Ziv Gan-Or, Thomas M Durcan, Luke M Healy

Förderung

  • NICHD NIH HHS
  • Canadian Institutes of Health Research
  • Canada First Research Excellence Fund
  • McGill University
  • Fonds de recherche du Québec—Santé
  • NIH
  • Eunice Kennedy Shriver National Institute of Child Health and Human Development
  • CIHR Foundation

Zitieren

APA

Dorion, M. F., Yaqubi, M., Senkevich, K., Kieran, N. W., MacDonald, A., Chen, C. X. Q., Luo, W., Wallis, A., Shlaifer, I., Hall, J. A., Dudley, R. W. R., Glass, I. A., Birth Defects Research Laboratory, Stratton, J. A., Fon, E. A., Bartels, T., Antel, J. P., Gan-Or, Z., Durcan, T. M., & Healy, L. M. (2024). MerTK is a mediator of alpha-synuclein fibril uptake by human microglia. Brain, 147(2), 427-443. https://doi.org/10.1093/brain/awad298

Vancouver

Dorion MF, Yaqubi M, Senkevich K, Kieran NW, MacDonald A, Chen CXQ, et al. MerTK is a mediator of alpha-synuclein fibril uptake by human microglia. Brain. 2024;147(2):427-443. doi:10.1093/brain/awad298

BibTeX
@article{Dorion2024,
  author = {Dorion, Marie-France and Yaqubi, Moein and Senkevich, Konstantin and Kieran, Nicholas W and MacDonald, Adam and Chen, Carol X Q and Luo, Wen and Wallis, Amber and Shlaifer, Irina and Hall, Jeffery A and Dudley, Roy W R and Glass, Ian A and Birth Defects Research Laboratory, Birth Defects Research Laboratory and Stratton, Jo Anne and Fon, Edward A and Bartels, Tim and Antel, Jack P and Gan-Or, Ziv and Durcan, Thomas M and Healy, Luke M},
  title = {MerTK is a mediator of alpha-synuclein fibril uptake by human microglia},
  journal = {Brain},
  year = {2024},
  volume = {147},
  number = {2},
  pages = {427--443},
  doi = {10.1093/brain/awad298}
}
Kostenlos starten →